TATSIANA BARR: Open Payments
NPI 1982322046 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 27 payments from 16 companies in 2025. Trend: 2023 $395 · 2024 $264 · 2025 $518
Food & beverage: $473Education: $45
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $125 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| MILLICENT US INC | 1 | $45 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $36 |
| Corcept Therapeutics | 2 | $35 |
| Exeltis, USA Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: Veozah, MYFEMBREE, Korlym, SLYND, Kyleena, t:slim X2 Insulin Pump with Control-IQ, REZDIFFRA, ZEPBOUND.
Industry payments across NJ — which companies pay providers there.
